Bcor功能不足促进骨髓增生异常综合征的发生与进展
研究分析缺失Bcor外显子9和10的小鼠(Bcor ΔE9-10/y),该突变表达的BCOR羧基端截短蛋白不能与多梳抑制复合物1.1的核心效应组分相互作用。Bcor ΔE9-10/y小鼠发生致死性T-ALL,其造血细胞在髓系区室显示生长优势;同时缺失Tet2后(Tet2 Δ/Δ Bcor ΔE9-10/y)小鼠发生致死性MDS,表现为进行性贫血和白细胞减少、无效造血及血细胞形态学发育异常。
要点
- Bcor ΔE9-10/y小鼠发生致死性T-ALL,类似Bcor ΔE4/y小鼠。
- Bcor ΔE9-10/y造血细胞在髓系区室显示生长优势,合并Tet2缺失后增强。
- Tet2 Δ/Δ Bcor ΔE9-10/y小鼠发生致死性MDS,伴贫血、白细胞减少和形态学发育异常。
核心结论
- 结果揭示BCOR在髓系恶性肿瘤中具有抑癌功能,并强调Bcor功能不足对MDS发生和进展的影响。
研究设计与样本
- 分析缺失Bcor外显子9和10的小鼠(Bcor ΔE9-10/y),该突变表达不能与多梳抑制复合物1.1核心效应组分相互作用的羧基端截短BCOR。
- 构建Tet2 Δ/Δ Bcor ΔE9-10/y小鼠,并将MDS细胞移植至二次受体。
主要发现
- Bcor ΔE9-10/y小鼠发生致死性T-ALL,方式与Bcor ΔE4/y小鼠相似。
- Bcor ΔE9-10/y造血细胞在髓系区室显示生长优势,同时缺失Tet2后该优势进一步增强。
- Tet2 Δ/Δ Bcor ΔE9-10/y小鼠发生致死性MDS,表现为进行性贫血和白细胞减少、无效造血及血细胞形态学发育异常。
- Tet2 Δ/Δ Bcor ΔE9-10/y MDS细胞在二次受体中重现MDS或演变为致死性MDS/骨髓增殖性肿瘤。
- 转录谱显示Bcor ΔE9-10/y祖细胞中Cebp家族和Hoxa簇髓系调节基因去抑制,MDS红系母细胞中p53靶基因激活并发生大量凋亡。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BCOR, encoding BCL-6 corepressor (BCOR), is X-linked and targeted by somatic mutations in various hematological malignancies including myelodysplastic syndrome (MDS). We previously reported that mice lacking Bcor exon 4 (Bcor ΔE4/y ) in the hematopoietic compartment developed NOTCH-dependent acute T-cell lymphoblastic leukemia (T-ALL). Here, we analyzed mice lacking Bcor exons 9 and 10 (Bcor ΔE9-10/y ), which express a carboxyl-terminal truncated BCOR that fails to interact with core effector components of polycomb repressive complex 1.1. Bcor ΔE9-10/y mice developed lethal T-ALL in a similar manner to Bcor ΔE4/y mice, whereas Bcor ΔE9-10/y hematopoietic cells showed a growth advantage in the myeloid compartment that was further enhanced by the concurrent deletion of Tet2 Tet2 Δ/Δ Bcor ΔE9-10/y mice developed lethal MDS with progressive anemia and leukocytopenia, inefficient hematopoiesis, and the morphological dysplasia of blood cells. Tet2 Δ/Δ Bcor ΔE9-10/y MDS cells reproduced MDS or evolved into lethal MDS/myeloproliferative neoplasms in secondary recipients. Transcriptional profiling revealed the derepression of myeloid regulator genes of the Cebp family and Hoxa cluster genes in Bcor ΔE9-10/y progenitor cells and the activation of p53 target genes specifically in MDS erythroblasts where massive apoptosis occurred. Our results reveal a tumor suppressor function of BCOR in myeloid malignancies and highlight the impact of Bcor insufficiency on the initiation and progression of MDS.
引用
- Tara S, Isshiki Y, Nakajima-Takagi Y, et al. Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome. Blood. 2018. PMID: 30228234. doi:10.1182/blood-2018-01-827964
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。